Optical Genome Mapping in Hematological Malignancies

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

Recruiting

Interested in participating?

Request Info

Key information

Conditions

MDS ALL Other Hematologic Malignant Neoplasms

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest, Brest, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Minor/Major Patients
Patients with suspected hemopathies for whom we receive a sample for diagnosis in the chromosomal genetics laboratory or for whom a diagnosis of hemopathy has already been made.
No objection made or consent given

Exclusion criteria

Patients under judicial protection (guardianship, curatorship, ...),
Refusal to participate

Treatment and study plan

Primary outcomes

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

Time frame: 2021-2026

identification of anomalies by mapping identical to those identified by combining conventional cytogenetics and FISH.

Secondary outcomes

identification of new chromosomal abnormalities of clinical relevance.

Time frame: 2021-2026
identification of new chromosomal anomalies involved in oncogenic pathways

Time frame: 2021-2026

Study contacts

Contact information is provided by the study sponsor or research team.

Marie-Bérengère, TROADEC, PhD

CONTACT

[email protected]

(33)230338055

Nathalie DOUET-GUILBERT, MD, PhD

CONTACT

[email protected]

(33)230338055

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: CARTOGEN

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2026
First posted: Aug 17, 2021
Registry last updated: Aug 17, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting